Patients were randomly assigned into six treatment groups each with a permutation of the treatment sequence ( ABC , BCA , etc. ) in the crossover phase ( 3 x 1 week ) and randomized to 23 weeks of either the daily flexible ( either regimen A , B or C ) or fixed timing ( only regimen A , B , or C ) in the patient 's preference phase .